UBS analyst Andrew Jones downgraded Nucor (NUE) to Neutral from Buy with a price target of $183, up from $168. The downgrade is based on “full” valuation and pricing, the analyst tells investors in a research note. The shares are up 32% since mid-October, despite a soft Q4, amid strong price moves in flat and longs and a $130/st in announced plate increases, the firm adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Nucor downgraded to Neutral from Buy at UBS
- Nucor: Mixed Q4 Performance and In-Line Outlook Justify Neutral Hold Rating
- Closing Bell Movers: Heath insurers slide on lower CMS rate increase plan
- Nucor Announces Q4 2025 Earnings and Dividend Declaration
- Nucor reports Q4 adjusted EPS $1.73, consensus $1.77